Addressing the PIP situation with heightened regulatory controls is playing to the crowd, especially when most of the new rules relate less to one act of fraud than they do ostensibly to innovation in the interests of patients.
medical
device
news
medical
device
news
Addressing the PIP situation with heightened regulatory controls is playing to the crowd, especially when most of the new rules relate less to one act of fraud than they do ostensibly to innovation in the interests of patients.